“Talking about something no one wants to talk about”—navigating hepatitis B-related work in remote Australian Aboriginal communities: a decade of learning and growth
-
Published:2024-04-15
Issue:1
Volume:3
Page:
-
ISSN:2731-7501
-
Container-title:Discover Health Systems
-
language:en
-
Short-container-title:Discov Health Systems
Author:
Binks PaulaORCID, Gurruwiwi George Garambaka, Dhurrkay Roslyn Gundjirryirr, Bukulatjpi Sarah Mariyalawuy, Ross Cheryl, Hosking Kelly, Tate-Baker Jaclyn, Marshall Catherine, McKinnon Melita, Vintour-Cesar Emily, Sullivan Richard P., Davis Joshua S., Hefler Marita, Davies Jane
Abstract
Abstract
Background
Chronic hepatitis B (CHB) is one of the leading causes of liver cirrhosis and liver cancer globally. In Australia, Aboriginal and Torres Strait Islander people of the Northern Territory (NT) have the highest prevalence of CHB (6%) and are six times more likely than non-Aboriginal people to be diagnosed with liver cancer. In 2010, a “liver one-stop shop” model of specialised care and research was initiated to address this disparity. Despite many challenges, the program was accepted in NT Aboriginal communities. This study aimed to identify the key elements linked to this success.
Methods
We conducted a retrospective case study using Stake’s methodology to understand the hepatitis B phenomenon. A constructivist approach allowed a holistic understanding from the real-life perspectives of those involved in the hepatitis B work. Information was sourced from the Aboriginal workforce, patients of remote clinics, interested community members and service providers.
Results
We identified six elements critical to the successful conduct of our hepatitis B program, which included the essential role of the local Aboriginal workforce, providing health education in a patient’s preferred language, addressing shame and stigma, respecting culture, taking time, and building trust in the community.
Conclusions
Commitment over the long term was crucial for the success of our hepatitis B program. Adhering to the identified elements was essential to create a culturally safe environment and engage more Aboriginal people in clinical care and research. This study provides powerful lessons and insights that can be applied to other programs and comparable settings worldwide.
Funder
National Health and Medical Council, Australia National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. World Health Organisation Hepatitis B Fact Sheet 2023. Updated 18 July 2023. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. 2. MacLachlan J, Romero N, Purcell I, Cowie B. Viral hepatitis mapping project: hepatitis B. National report 2021. Darlinghurst, NSW; Australasian Society for HIV, Viral Hepatitis, and sexual health medicine (ASHM), 2023. https://ashm.org.au/resources/viral-hepatitis-mapping-project/. 3. Davies J, Li SQ, Tong SY, Baird RW, Beaman M, Higgins G, Cowie BC, Condon J, Davis JS. Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population. PLoS ONE. 2017;12(9): e0184082. 4. Lubel JS, Strasser SI, Thompson AJ, Cowie BC, MacLachlan J, Allard NL, Holmes J, Kemp WW, Majumdar A, Iser D, Howell J, Matthews GV. Australian consensus recommendations for the management of hepatitis B. Med J Aust. 2022;216(9):478–86. 5. Parker C, Tong SY, Dempsey K, Condon J, Sharma SK, Chen JW, Sievert W, Davies JS. Hepatocellular carcinoma in Australia’s Northern Territory: high incidence and poor outcome. Med J Aust. 2014;201(8):470–4.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|